Cipla

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE059A01026
  • NSEID: CIPLA
  • BSEID: 500087
INR
1,330.00
-3.3 (-0.25%)
BSENSE

Feb 06

BSE+NSE Vol: 15.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,330.00",
    "chg": -3.3,
    "chgp": "-0.25%",
    "dir": -1,
    "prev_price": "1,333.30",
    "mcapval": "106,680.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE059A01026",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "15.33 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cipla-597145-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-amidst-nifty-50-membership-and-sector-dynamics-3823817",
        "imagepath": "",
        "date": "2026-02-06 09:20:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a key component of the Nifty 50, Cipla Ltd. holds considerable influence on the benchmark’s pharmaceutical segment representation. Inclusion in this index not only enhances the stock’s visibility among institutional investors but also ensures substantial passive fund inflows, given the widespread use of the Nifty 50 as a market barometer. However, this membership also subjects Cipla to heightened scrutiny and volatility, especially when its fundamentals diverge from broader market trends.</p>\n                <p>Currently, Cipla’s market capitalisation stands at a robust ₹1,06,627.05 crores, categorising it firmly as a large-cap stock. This stature typically confers stability and investor confidence, yet Cip..."
      },
      {
        "title": "Cipla Ltd. Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-amid-bearish-signals-3821663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CiplaLtd_technicaldot_3821663.png",
        "date": "2026-02-05 08:02:47",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 0.23%, the stock’s broader technical landscape suggests caution for investors as multiple metrics point towards weakening momentum and potential downside risks."
      },
      {
        "title": "Cipla Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-amid-mixed-market-signals-3819663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CiplaLtd_technicaldot_3819663.png",
        "date": "2026-02-04 08:03:22",
        "description": "Cipla Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest daily price gain of 0.93%, the stock’s broader technical indicators reveal a cautious outlook, prompting a downgrade in its Mojo Grade from Hold to Sell as of 7 January 2026."
      },
      {
        "title": "Cipla Ltd. Technical Momentum Shifts to Bearish Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-to-bearish-amid-market-underperformance-3817173",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CiplaLtd_technicaldot_3817173.png",
        "date": "2026-02-03 08:02:22",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Cipla Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-amid-mixed-market-signals-3815390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CiplaLtd_technicaldot_3815390.png",
        "date": "2026-02-02 08:02:53",
        "description": "Cipla Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle yet notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.14%, the stock’s recent downgrade from Hold to Sell by MarketsMOJO on 7 January 2026 highlights growing caution among analysts amid mixed technical indicators and underwhelming relative returns compared to the broader Sensex."
      },
      {
        "title": "Cipla Ltd Faces Headwinds Amid Nifty 50 Membership and Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-faces-headwinds-amid-nifty-50-membership-and-institutional-shifts-3813865",
        "imagepath": "",
        "date": "2026-02-01 09:20:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Impact</strong></p>\n                <p>As a prominent member of the Nifty 50, Cipla Ltd. holds a significant position in India’s benchmark equity index, which comprises the 50 largest and most liquid stocks listed on the National Stock Exchange. Inclusion in this index not only enhances visibility among domestic and global investors but also ensures substantial passive fund inflows from index-tracking mutual funds and exchange-traded funds (ETFs). Consequently, any change in Cipla’s fundamentals or market perception can have amplified effects on its stock price and trading volumes.</p>\n                <p>However, Cipla’s recent underperformance relative to the broader market has raised concerns. The stock closed at ₹1,347.50, hovering just 4.86% abo..."
      },
      {
        "title": "Cipla Ltd Gains 0.69%: 2 Key Factors Driving the Week’s Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-gains-069-2-key-factors-driving-the-weeks-mixed-performance-3813084",
        "imagepath": "",
        "date": "2026-01-31 16:09:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Cipla hits 52-week low of Rs.1,283 amid continued downtrend</p>\n                    <p><strong>27 Jan:</strong> Reports sharp 35.0% decline in quarterly PAT, signalling negative financial trend</p>\n                    <p><strong>30 Jan:</strong> Week closes at Rs.1,323.95, up 0.69% for the week but underperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,314.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,323.95</div><div class=\"stat-change pos..."
      },
      {
        "title": "Cipla Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cipla-ltd-is-rated-sell-by-marketsmojo-3811205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CiplaLtd_mojoScore_3811205.png",
        "date": "2026-01-30 10:10:03",
        "description": "Cipla Ltd. is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the stock's present condition as of 30 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-amidst-nifty-50-membership-and-sector-dynamics-3810791",
        "imagepath": "",
        "date": "2026-01-30 09:20:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Cipla Ltd., attracting a broad spectrum of institutional investors and index funds. This membership not only enhances the stock’s trading volumes but also integrates it into numerous passive investment strategies, thereby amplifying its market impact. However, inclusion also subjects Cipla to heightened scrutiny and performance expectations, especially as the index serves as a barometer for India’s blue-chip equities.</p>\n                <p>In the current market environment, Cipla’s position within the Nifty 50 is a double-edged sword. While it benefits from steady institutional inflows, the stock’s recent price action..."
      }
    ],
    "total": 930,
    "sid": "597145",
    "stock_news_url": "https://www.marketsmojo.com/news/cipla-597145"
  },
  "announcements": [
    {
      "details": "Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Cipla Limited has informed the Exchange that its wholly owned subsidiary Cipla (EU) Limited, holding 60% stake in Cipla Pharma Lanka (Private) Limited {Cipla Pharma Lanka), Sri Lanka, has signed an agreement with CitiHealth Imports",
      "source": "NSE",
      "caption": "Cipla Limited - Acquisition",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "21-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Sector Dynamics

2026-02-06 09:20:47

Significance of Nifty 50 Membership

As a key component of the Nifty 50, Cipla Ltd. holds considerable influence on the benchmark’s pharmaceutical segment representation. Inclusion in this index not only enhances the stock’s visibility among institutional investors but also ensures substantial passive fund inflows, given the widespread use of the Nifty 50 as a market barometer. However, this membership also subjects Cipla to heightened scrutiny and volatility, especially when its fundamentals diverge from broader market trends.

Currently, Cipla’s market capitalisation stands at a robust ₹1,06,627.05 crores, categorising it firmly as a large-cap stock. This stature typically confers stability and investor confidence, yet Cip...

Read full news article

Cipla Ltd Faces Headwinds Amid Nifty 50 Membership and Institutional Shifts

2026-02-01 09:20:48

Index Membership and Market Impact

As a prominent member of the Nifty 50, Cipla Ltd. holds a significant position in India’s benchmark equity index, which comprises the 50 largest and most liquid stocks listed on the National Stock Exchange. Inclusion in this index not only enhances visibility among domestic and global investors but also ensures substantial passive fund inflows from index-tracking mutual funds and exchange-traded funds (ETFs). Consequently, any change in Cipla’s fundamentals or market perception can have amplified effects on its stock price and trading volumes.

However, Cipla’s recent underperformance relative to the broader market has raised concerns. The stock closed at ₹1,347.50, hovering just 4.86% abo...

Read full news article

Cipla Ltd Gains 0.69%: 2 Key Factors Driving the Week’s Mixed Performance

2026-01-31 16:09:02

Key Events This Week

27 Jan: Cipla hits 52-week low of Rs.1,283 amid continued downtrend

27 Jan: Reports sharp 35.0% decline in quarterly PAT, signalling negative financial trend

30 Jan: Week closes at Rs.1,323.95, up 0.69% for the week but underperforming Sensex

stock-recommendationAnnouncement

Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates

09-Dec-2019 | Source : NSE

Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Cipla Limited - Acquisition

28-Nov-2019 | Source : NSE

Cipla Limited has informed the Exchange that its wholly owned subsidiary Cipla (EU) Limited, holding 60% stake in Cipla Pharma Lanka (Private) Limited {Cipla Pharma Lanka), Sri Lanka, has signed an agreement with CitiHealth Imports

Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates

21-Nov-2019 | Source : NSE

Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Cipla Ltd. has declared 650% dividend, ex-date: 27 Jun 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Cipla Ltd. has announced 3:2 bonus issue, ex-date: 24 Apr 06

stock-summary
RIGHTS

No Rights history available